Author

A. Croft

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:cell-cell communication· 3 Research Focus:differential expression· 3 Approach:experimental assay· 3 Organism:human· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J. Turner· 2 shared A. Abdulsalam· 1 shared A. Filer· 1 shared A. Heagerty· 1 shared A. O. Khan· 1 shared A. Orville· 1 shared A. Prince· 1 shared A. Quigley· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. Turner

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cellular heterogeneity in hypertrophic burn scars in response to carbon dioxide laser therapy

Y.-Y. Chen, C. Mahon, J. Turner, C. M. Smith, A. Abdulsalam, E. Amirize, A. Prince, A. Heagerty, C. Roberts, A. Croft, Y. Wilson, N. Moiemen, J. Lord

This study uses single-cell RNA sequencing to analyze how hypertrophic burn scars respond to carbon dioxide laser therapy, identifying gene expression patterns and cell types associated with good or poor outcomes.

Communications Medicine · Apr 10, 2026Peer-reviewedCell Biology

The adaptability of the ion binding site by the Ag(I)/Cu(I) periplasmic chaperone SilF.

R. Lithgo, M. Hanzevacki, G. Harris, J. Kamps, E. Holden, J. L. Benesch, C. Jager, A. Croft, J. Hobman, A. Orville, A. Quigley, S. Carr, D. Scott

This study shows SilF, a periplasmic chaperone, binds both Ag(I) and Cu(I) with similar affinities, suggesting Gram-negative bacteria use an existing Cu(I) detox system for Ag(I) resistance.

bioRxiv · Mar 31, 2023Biophysics

Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies

A. O. Khan, M. Colombo, J. S. Reyat, G. Wang, A. Rodriguez-Romera, W. X. Wen, L. Murphy, B. Grygielska, C. Mahony, A. Stone, A. Croft, D. C. Bassett, G. Pooligasundarampillai, A. Roy, S. Gooding, , B. Psaila

This paper develops human bone marrow organoids to model hematological malignancies and validate therapeutic targets.

bioRxiv · Mar 14, 2022Cancer Biology

Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis

A. Croft, J. Campos, K. Jansen, J. Turner, J. Marshall, M. Attar, L. Savary, H. Perlman, F. Barone, H. McGettrick, D. Fearon, K. Wei, S. Raychaudhuri, I. Lorsunsky, M. Brenner, , C. D. Buckley

The paper identifies two distinct fibroblast subsets in arthritis that drive inflammation or tissue damage, showing their unique roles in disease progression.

bioRxiv · Jul 23, 2018 · PreprintImmunology